Trial result ·
Adjunctive psychobiotic Lactiplantibacillus plantarum PS128 ameliorates gastrointestinal comorbidities and alters circulating miRNAs and gut microbiota in children with Tourette syndrome: a randomized controlled trial.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This trial tested a germ strain called Lactiplantibacillus plantarum PS128. It is thought to act on the brain. It was tested as an add-on for children with Tourette syndrome. The children were aged 4 to 18 years. By chance, each child got PS128 or a dummy product for 12 weeks. Neither the families nor the study team knew who got which. The team scored tics, focus and stomach upset. They also checked molecules in the blood called miRNAs, and gut germs in stool.
What they found
The main goal was a drop in tic scores. This drop did not differ between the groups. Both groups also did about the same on other tic and thinking tests. Children on PS128 had a larger drop in stomach symptoms. This was mainly pain in the upper belly. There was a trend toward better focus on an attention test. Blood levels of miR-199a-3p and miR-143-3p rose more with PS128. Stool showed more Lactiplantibacillus germs after PS128. More of this germ was linked to higher miR-199a-3p. It was also linked to lower scores on a doctor's overall rating. No harms from PS128 were reported.
What it means for patients
PS128 did not seem to ease tics in these children. It may help with stomach upset and possibly with focus. These changes came with shifts in blood molecules and gut germs. The authors say PS128 is worth more study. They see it as a possible add-on for children with Tourette syndrome.
Why it is not certain yet
The main goal of the trial, fewer tics, was not met. The gain in focus was only a trend, not a clear result. The abstract does not say how many children started the trial. The links between germs, blood molecules and symptoms show ties, not cause. The role of the blood molecules was only predicted, not tested directly.
Source
Adjunctive psychobiotic Lactiplantibacillus plantarum PS128 ameliorates gastrointestinal comorbidities and alters circulating miRNAs and gut microbiota in children with Tourette syndrome: a randomized controlled trial.
PubMed · PMID 42626970We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Tourette syndrome publications